Key Statistics

Live data from ClinicalTrials.gov showing all actively recruiting mesothelioma trials.

Active Recruiting Trials

Total mesothelioma trials currently recruiting patients

90 recruiting trials ClinicalTrials.gov, January 2026 Source: ClinicalTrials.gov
Data from MesoWatch. Free to use with attribution.

U.S. Trials

Trials available in the United States

52 trials in the U.S. 56% of all recruiting trials Source: ClinicalTrials.gov
Data from MesoWatch. Free to use with attribution.

Immunotherapy Trials

Trials testing immunotherapy approaches

33 immunotherapy trials Leading category in research Source: ClinicalTrials.gov
Data from MesoWatch. Free to use with attribution.

CAR-T Trials

CAR-T cell therapy trials for mesothelioma

4 CAR-T trials Emerging treatment frontier Source: ClinicalTrials.gov
Data from MesoWatch. Free to use with attribution.

Trials by Treatment Category

Breakdown of what types of treatments are being tested in mesothelioma clinical trials.

Trials by Treatment Type

Distribution of active trials by treatment category

Trials by Treatment Category 90 total recruiting trials Immunotherapy: 33 (36.7%) Chemotherapy: 14 (15.6%) Surgery: 7 (7.8%) Targeted: 6 (6.7%) CAR-T: 4 (4.4%) Other: 26 (28.9%) 90 TOTAL Immunotherapy: 33 (36.7%) Immunotherapy 33 • 36.7% Chemotherapy: 14 (15.6%) Chemotherapy 14 • 15.6% Surgery: 7 (7.8%) Surgery 7 • 7.8% Targeted: 6 (6.7%) Targeted 6 • 6.7% CAR-T: 4 (4.4%) CAR-T 4 • 4.4% Other: 26 (28.9%) Other 26 • 28.9% Source: ClinicalTrials.gov
Data from MesoWatch. Free to use with attribution.

Trials by Phase

Clinical trial phases indicate how far along a treatment is in the development process. Phase 3 trials are closest to FDA approval.

Trials by Phase

Distribution of trials by development stage

Active Trials by Phase Phase 3 trials lead to FDA approval Phase 1 Phase 1 Phase 1: 21 trials 21 trials Phase 1/2 Phase 1/2 Phase 1/2: 16 trials 16 trials Phase 2 Phase 2 Phase 2: 18 trials 18 trials Phase 3 Phase 3 Phase 3: 1 trials 1 trials Source: ClinicalTrials.gov
Data from MesoWatch. Free to use with attribution.

Top States for Trial Access

States with the most mesothelioma clinical trial sites. Larger states and those with major cancer centers have more options.

Top 10 States by Trial Sites

U.S. states with the most mesothelioma trial locations

Top 10 States by Trial Sites Where patients have the most trial options Texas Texas Texas: 50 sites 50 sites Nevada Nevada Nevada: 41 sites 41 sites Illinois Illinois Illinois: 38 sites 38 sites New York New York New York: 33 sites 33 sites California California California: 32 sites 32 sites Washington Washington Washington: 32 sites 32 sites Florida Florida Florida: 27 sites 27 sites Minnesota Minnesota Minnesota: 24 sites 24 sites New Jersey New Jersey New Jersey: 20 sites 20 sites Pennsylvania Pennsylvania Pennsylvania: 18 sites 18 sites Source: ClinicalTrials.gov
Data from MesoWatch. Free to use with attribution.

Global Distribution

Mesothelioma research is a global effort. The U.S. leads, but significant research is happening in China, Europe, and beyond.

Trials by Country

Global distribution of mesothelioma clinical trials

Trials by Country 93 trials across 25+ countries United States: 52 (47.7%) China: 14 (12.8%) United Kingdom: 9 (8.3%) Italy: 9 (8.3%) France: 8 (7.3%) Other: 17 (15.6%) 109 TOTAL United States: 52 (47.7%) United States 52 • 47.7% China: 14 (12.8%) China 14 • 12.8% United Kingdom: 9 (8.3%) United Kingdom 9 • 8.3% Italy: 9 (8.3%) Italy 9 • 8.3% France: 8 (7.3%) France 8 • 7.3% Other: 17 (15.6%) Other 17 • 15.6% Source: ClinicalTrials.gov
Data from MesoWatch. Free to use with attribution.

How to Use These Visualizations

Embed on Your Website

Click "Copy Embed Code" to get an iframe snippet. Attribution to MesoWatch is included.

Download for Presentations

Download SVG or PNG versions. SVG preserves quality at any size.

Share on Social Media

PNG downloads are optimized for social sharing.

Attribution

Free to use with attribution. Link back to mesowatch.org when sharing.

Data Source

All clinical trial data is sourced directly from the official U.S. government clinical trials registry.

Data is refreshed daily. Last update: June 16, 2026